Phoenix Group, the German drug wholesaler started by the late billionaire Adolf Merckle, is considering an IPO as well as a sale, reports Bloomberg. Deutsche Bank, which is overseeing the sale, is weighing a dual-track process, where a bank simultaneously prepares a company for an IPO and lines up potential bidders, say people close to the matter. Phoenix may be valued at about €5.5bn to €6bn ($8.5bn), and an IPO would take place next year at the earliest.

This entry was posted by Gwen Robinson on Wednesday, August 19th, 2009 at 4:50 and is filed under Uncategorised. Tagged with deutsche bank, Phoenix. Edit this entry.